Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

China · Delayed Price · Currency is CNY

18.44

-0.37 (-1.97%)

Feb 13, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Medicine	1.94B	2.61B	2.02B	1.81B	1.91B
Medicine Growth	-25.68%	29.26%	11.32%	-4.89%	-32.51%
Chain drugstore wholesale and retail	392.49M	375.02M	448.39M	248.49M	141.50M
Chain drugstore wholesale and retail Growth	4.66%	-16.36%	80.45%	75.61%	85.76%
Food	236.14M	363.28M	359.32M	155.58M	140.75M
Food Growth	-35.00%	1.10%	130.95%	10.54%	9.95%
Other Segment	268.15M	56.78M	24.59M	45.81M	48.32M
Other Segment Growth	372.23%	130.96%	-46.33%	-5.19%	-9.36%
Unallocated Other Operating Income	-	45.58M	17.95M	41.05M	15.11M
Unallocated Other Operating Income Growth	-	153.85%	-56.27%	171.69%	116.32%
Offset of Business Segment	-226.48M	-	-	-	-
Group Investment Division	1.72M	-	-	-	-
Total	2.61B	3.45B	2.87B	2.30B	2.25B
Total Growth	-24.31%	20.25%	24.50%	2.31%	-27.09%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
North East China	968.31M	1.14B	1.08B	704.81M	-
North East China Growth	-14.76%	5.01%	53.49%	-	-
North China	377.55M	270.10M	242.04M	217.61M	-
North China Growth	39.78%	11.59%	11.23%	-	-
East China	485.27M	978.65M	682.98M	602.64M	-
East China Growth	-50.42%	43.29%	13.33%	-	-
South China	330.18M	414.79M	363.68M	319.41M	-
South China Growth	-20.40%	14.05%	13.86%	-	-
Northwest China	149.89M	235.88M	197.79M	162.96M	-
Northwest China Growth	-36.46%	19.26%	21.37%	-	-
Southwest China	299.39M	413.75M	299.81M	296.35M	-
Southwest China Growth	-27.64%	38.01%	1.17%	-	-
Foreign	-	-	117.23K	-	-
China	-	-	-	-	2.25B
China Growth	-	-	-	-	-27.09%
Total	2.61B	3.45B	2.87B	2.30B	2.25B
Total Growth	-24.31%	20.25%	24.50%	2.31%	-27.09%

Source: S&P Global Market Intelligence.